Strongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate Updates
November 05, 2019 06:30 ET
|
Strongbridge Biopharma plc
DUBLIN, Ireland and TREVOSE, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019
October 29, 2019 07:30 ET
|
Strongbridge Biopharma plc
DUBLIN, Ireland and TREVOSE, Pa., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting
October 17, 2019 07:30 ET
|
Strongbridge Biopharma plc
DUBLIN, Ireland and TREVOSE, Pa., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
Strongbridge Biopharma plc to Present at the 2019 Cantor Global Healthcare Conference
September 25, 2019 09:04 ET
|
Strongbridge Biopharma plc
DUBLIN, Ireland and TREVOSE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
Strongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & Endocrinology
September 19, 2019 07:30 ET
|
Strongbridge Biopharma plc
~ RECORLEV Resulted in Sustained Improvements in Urinary Free Cortisol (UFC) and Provided Clinical Benefit, As Demonstrated By Improvements in Comorbidities and Characteristic Signs and Symptoms of...
Strongbridge Biopharma plc to Present at the H.C. Wainwright 21st Annual Global Investment Conference and the Janney Montgomery Scott Healthcare Conference 2019
September 03, 2019 07:30 ET
|
Strongbridge Biopharma plc
DUBLIN, Ireland and TREVOSE, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth
August 13, 2019 08:45 ET
|
Strongbridge Biopharma plc
~ Richard S. Kollender Appointed to Chief Operating Officer ~ ~ Robert Lutz Promoted to Chief Financial Officer ~ ~ David Gill Appointed to Board of Directors ~ DUBLIN, Ireland and TREVOSE, Pa.,...
Strongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update
July 31, 2019 07:30 ET
|
Strongbridge Biopharma plc
~ KEVEYIS® (dichlorphenamide) Second Quarter 2019 Revenue of $6.1 Million ~ ~ Company on Track to Meet Full-Year 2019 KEVEYIS® Revenue Guidance of $18 to $20 Million ~ ~ Enrollment in Phase 3 LOGICS...
Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019
July 24, 2019 07:30 ET
|
Strongbridge Biopharma plc
DUBLIN, Ireland and TREVOSE, Pa., July 24, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
Strongbridge Biopharma plc Announces New Employment Inducement Awards
July 19, 2019 07:30 ET
|
Strongbridge Biopharma plc
DUBLIN, Ireland and TREVOSE, Pa., July 19, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and...